VanRx_Mike said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

JakeBK_lifts said:

The mechanism that matters here is not stomach emptying, it is central.

That reframing is the part I needed.

VanRx_Mike said:

Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

Worth separating that from compounded supply, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

The figures, for anyone assembling their own picture. Two things anyone can check: a state licence number for a 503A, and an FDA outsourcing-facility registration for a 503B. Both are publicly searchable, and a pharmacy unwilling to give you either has answered the question.

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Carry on.